It should also be noted that a recent analysis of thousands of human tumors found no evidence of specific BECN1 deletions or somatic mutations but instead concluded that the apparent loss of BECN1 in human cancer is most likely due to deletion of the adjacent BRCA1 gene, which is a well-known tumor suppressor [26]. This evidence concerns the gene BECN1 and cancer.